CEO of Bionano Genomics Sees Future Upside, Buys 69K Stock Options Amid 75% Share Decline
CEO’s insider option purchase signals confidence in Bionano’s genomics platform—investors should watch upcoming filings for a potential turnaround.
3 minutes to read

